145 related articles for article (PubMed ID: 29473345)
1. CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Yang Y; Shi Y; Hou Y; Lu Y; Yang J
Cancer Med; 2018 Mar; 7(3):716-725. PubMed ID: 29473345
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
3. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
Zhao W; Wang Y; Yue X
Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
[TBL] [Abstract][Full Text] [Related]
4. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.
Yu T; Jia W; An Q; Cao X; Xiao G
Med Sci Monit; 2018 Mar; 24():1847-1855. PubMed ID: 29596399
[TBL] [Abstract][Full Text] [Related]
6. CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer.
Ji B; Qiao L; Zhai W
Dig Dis Sci; 2023 Mar; 68(3):791-802. PubMed ID: 35624327
[TBL] [Abstract][Full Text] [Related]
7. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
8. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
Wang X; Meng Q; Wang Y; Gao Y
Medicine (Baltimore); 2021 Aug; 100(32):e26545. PubMed ID: 34397871
[TBL] [Abstract][Full Text] [Related]
10. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
11. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
12. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
13. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
[TBL] [Abstract][Full Text] [Related]
16. HAVCR1 expression might be a novel prognostic factor for gastric cancer.
Liu L; Song Z; Zhao Y; Li C; Wei H; Ma J; Du Y
PLoS One; 2018; 13(11):e0206423. PubMed ID: 30388143
[TBL] [Abstract][Full Text] [Related]
17. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
18. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
Kim HS; Chon HJ; Kim H; Shin SJ; Wacheck V; Gruver AM; Kim JS; Rha SY; Chung HC
J Surg Oncol; 2018 Jun; 117(8):1679-1686. PubMed ID: 29790169
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]